@misc{indiciae6badbf117095,
  title = {Response to azacitidine and the TIM-3 inhibitor, sabatolimab, in MDS and CMML is associated with distinct immune and antigen-presentation states},
  author = {Dey, A. and Smith, N. and Tirard, A. and Arnold, B. and Chan, T. and Lombardi-Story, J. and Casson, T. and Behnan, T. T. and Aguilar-Fernandez, S. and Fathi, A. T. and Hobbs, G. S. and Hock, H. and Amrein, P. C. and Reeves, P. and Jan, M. and Bod, L. and Graubert, T. A. and Brunner, A. M. and Narayan, R. and Villani, A.-C.},
  year = {2026},
  doi = {10.64898/2026.11.04.764360},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.04.764360v1},
  note = {Source identifier: 10.64898/2026.11.04.764360}
}